TipRanks
Natera (NTRA)
NASDAQ:NTRA
US Market
NTRA
Natera
RESEARCH TOOLSreports
Want to see NTRA full AI Analyst Report?

Natera (NTRA) Stock Forecast & Price Target

1,347 Followers
See the Price Targets and Ratings of:

NTRA Analyst Ratings

Strong Buy
20Ratings
Strong Buy
19 Buy
1 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Natera
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NTRA Stock 12 Month Forecast

Average Price Target

$400.08
▲(18.82% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $400.08 with a high forecast of $480.00 and a low forecast of $320.00. The average price target represents a 18.82% change from the last price of $336.71.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"160":"$160","481":"$481","240.25":"$240.3","320.5":"$320.5","400.75":"$400.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":480,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$480.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":400.078947368421,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$400.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":320,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$320.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[160,240.25,320.5,400.75,481],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,408.47,413.9723076923077,419.4746153846154,424.9769230769231,430.4792307692308,435.9815384615385,441.4838461538462,446.98615384615385,452.48846153846154,457.9907692307692,463.49307692307696,468.99538461538464,474.4976923076923,{"y":480,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,408.47,407.8245344129555,407.1790688259109,406.5336032388664,405.88813765182186,405.2426720647773,404.59720647773275,403.95174089068826,403.3062753036437,402.66080971659915,402.0153441295546,401.3698785425101,400.72441295546554,{"y":400.078947368421,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,408.47,401.6646153846154,394.8592307692308,388.05384615384617,381.2484615384616,374.44307692307694,367.6376923076923,360.8323076923077,354.0269230769231,347.22153846153844,340.41615384615386,333.6107692307692,326.80538461538464,{"y":320,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":161.61,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.25,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.09,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.17,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.21,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.28,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.81,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":276.27,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.76,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":320.76,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":408.47,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$480.00Average Price Target$400.08Lowest Price Target$320.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on NTRA
Casey Woodring
J.P. Morgan
J.P. Morgan
$360→$460
Buy
36.62%
Upside
Reiterated
10/14/26
Natera price target raised to $460 from $360 at JPMorganNatera price target raised to $460 from $360 at JPMorgan
TD Cowen Analyst forecast on NTRA
Daniel Brennan
TD Cowen
TD Cowen
$340→$480
Buy
42.56%
Upside
Reiterated
10/13/26
Natera price target raised to $480 from $340 at TD CowenNatera price target raised to $480 from $340 at TD Cowen
Morgan Stanley Analyst forecast on NTRA
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$355→$435
Buy
29.19%
Upside
Assigned
10/13/26
Natera price target raised to $435 from $355 at Morgan StanleyNatera price target raised to $435 from $355 at Morgan Stanley
Bernstein Analyst forecast on NTRA
Eve Burstein
Bernstein
Bernstein
$365
Buy
8.40%
Upside
Reiterated
10/12/26
Natera (NTRA) Receives a Buy from Bernstein
Barclays Analyst forecast on NTRA
Luke Sergott
Barclays
Barclays
$340→$475
Buy
41.07%
Upside
Reiterated
10/07/26
Barclays Reaffirms Their Buy Rating on Natera (NTRA)
Citi Analyst forecast on NTRA
Albert Hu‏
Citi
Citi
$365→$480
Buy
42.56%
Upside
Reiterated
10/06/26
Natera price target raised to $480 from $365 at CitiNatera price target raised to $480 from $365 at Citi
Guggenheim Analyst forecast on NTRA
Subbu Nambi
Guggenheim
Guggenheim
$360→$475
Buy
41.07%
Upside
Reiterated
10/01/26
Natera price target raised to $475 from $360 at GuggenheimNatera price target raised to $475 from $360 at Guggenheim
RBC Capital Analyst forecast on NTRA
Dan Leonard
RBC Capital
RBC Capital
$350→$460
Buy
36.62%
Upside
Reiterated
09/24/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on NTRA
Evie Koslosky
Goldman Sachs
Goldman Sachs
$290→$375
Hold
11.37%
Upside
Reiterated
09/20/26
Goldman Sachs Keeps Their Hold Rating on Natera (NTRA)
UBS Analyst forecast on NTRA
Doug Schenkel
UBS
UBS
$290→$435
Buy
29.19%
Upside
Reiterated
09/09/26
Natera assumed with a Buy at UBSNatera assumed with a Buy at UBS
Rothschild & Co Redburn Analyst forecast on NTRA
Jamie Clark
Rothschild & Co Redburn
Rothschild & Co Redburn
$385
Buy
14.34%
Upside
Initiated
09/08/26
Natera initiated with a Buy at Rothschild & Co RedburnNatera initiated with a Buy at Rothschild & Co Redburn
Piper Sandler Analyst forecast on NTRA
David Westenberg
Piper Sandler
Piper Sandler
$363.5
Buy
7.96%
Upside
Reiterated
08/24/26
Analysts Conflicted on These Healthcare Names: Natera (NASDAQ: NTRA), Healthequity (NASDAQ: HQY) and CSPC Pharmaceutical Group (Other OTC: CHJTF)
Jefferies Analyst forecast on NTRA
Tycho Peterson
Jefferies
Jefferies
$330
Buy
-1.99%
Downside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG) and Natera (NASDAQ: NTRA)
Stephens Analyst forecast on NTRA
Unknown Analyst
Stephens
Not Ranked
Stephens
$350
Buy
3.95%
Upside
Reiterated
08/12/26
Stephens Keeps Their Buy Rating on Natera (NTRA)
Canaccord Genuity Analyst forecast on NTRA
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
$330→$375
Buy
11.37%
Upside
Reiterated
08/07/26
Natera price target raised to $375 from $330 at CanaccordNatera price target raised to $375 from $330 at Canaccord
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on NTRA
Casey Woodring
J.P. Morgan
J.P. Morgan
$360→$460
Buy
36.62%
Upside
Reiterated
10/14/26
Natera price target raised to $460 from $360 at JPMorganNatera price target raised to $460 from $360 at JPMorgan
TD Cowen Analyst forecast on NTRA
Daniel Brennan
TD Cowen
TD Cowen
$340→$480
Buy
42.56%
Upside
Reiterated
10/13/26
Natera price target raised to $480 from $340 at TD CowenNatera price target raised to $480 from $340 at TD Cowen
Morgan Stanley Analyst forecast on NTRA
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$355→$435
Buy
29.19%
Upside
Assigned
10/13/26
Natera price target raised to $435 from $355 at Morgan StanleyNatera price target raised to $435 from $355 at Morgan Stanley
Bernstein Analyst forecast on NTRA
Eve Burstein
Bernstein
Bernstein
$365
Buy
8.40%
Upside
Reiterated
10/12/26
Natera (NTRA) Receives a Buy from Bernstein
Barclays Analyst forecast on NTRA
Luke Sergott
Barclays
Barclays
$340→$475
Buy
41.07%
Upside
Reiterated
10/07/26
Barclays Reaffirms Their Buy Rating on Natera (NTRA)
Citi Analyst forecast on NTRA
Albert Hu‏
Citi
Citi
$365→$480
Buy
42.56%
Upside
Reiterated
10/06/26
Natera price target raised to $480 from $365 at CitiNatera price target raised to $480 from $365 at Citi
Guggenheim Analyst forecast on NTRA
Subbu Nambi
Guggenheim
Guggenheim
$360→$475
Buy
41.07%
Upside
Reiterated
10/01/26
Natera price target raised to $475 from $360 at GuggenheimNatera price target raised to $475 from $360 at Guggenheim
RBC Capital Analyst forecast on NTRA
Dan Leonard
RBC Capital
RBC Capital
$350→$460
Buy
36.62%
Upside
Reiterated
09/24/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on NTRA
Evie Koslosky
Goldman Sachs
Goldman Sachs
$290→$375
Hold
11.37%
Upside
Reiterated
09/20/26
Goldman Sachs Keeps Their Hold Rating on Natera (NTRA)
UBS Analyst forecast on NTRA
Doug Schenkel
UBS
UBS
$290→$435
Buy
29.19%
Upside
Reiterated
09/09/26
Natera assumed with a Buy at UBSNatera assumed with a Buy at UBS
Rothschild & Co Redburn Analyst forecast on NTRA
Jamie Clark
Rothschild & Co Redburn
Rothschild & Co Redburn
$385
Buy
14.34%
Upside
Initiated
09/08/26
Natera initiated with a Buy at Rothschild & Co RedburnNatera initiated with a Buy at Rothschild & Co Redburn
Piper Sandler Analyst forecast on NTRA
David Westenberg
Piper Sandler
Piper Sandler
$363.5
Buy
7.96%
Upside
Reiterated
08/24/26
Analysts Conflicted on These Healthcare Names: Natera (NASDAQ: NTRA), Healthequity (NASDAQ: HQY) and CSPC Pharmaceutical Group (Other OTC: CHJTF)
Jefferies Analyst forecast on NTRA
Tycho Peterson
Jefferies
Jefferies
$330
Buy
-1.99%
Downside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Adagene (NASDAQ: ADAG) and Natera (NASDAQ: NTRA)
Stephens Analyst forecast on NTRA
Unknown Analyst
Stephens
Not Ranked
Stephens
$350
Buy
3.95%
Upside
Reiterated
08/12/26
Stephens Keeps Their Buy Rating on Natera (NTRA)
Canaccord Genuity Analyst forecast on NTRA
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
$330→$375
Buy
11.37%
Upside
Reiterated
08/07/26
Natera price target raised to $375 from $330 at CanaccordNatera price target raised to $375 from $330 at Canaccord
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
REPLReplimune Group
OVIDOvid Therapeutics
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months
Catherine Ramsey SchulteRobert W. Baird
Success Rate
29/41 ratings generated profit
71%
Average Return
+14.73%
Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 70.73% of your transactions generating a profit, with an average return of +14.73% per trade.
1 Year
Daniel BrennanTD Cowen
Success Rate
21/21 ratings generated profit
100%
Average Return
+75.15%
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +75.15% per trade.
2 Years
Puneet SoudaLeerink Partners
Success Rate
34/34 ratings generated profit
100%
Average Return
+174.39%
Copying Puneet Souda's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +174.39% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NTRA Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
25
30
38
35
33
Hold
3
5
5
5
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
35
43
40
36
In the current month, NTRA has received 33 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. NTRA average Analyst price target in the past 3 months is 400.08.
Each month's total comprises the sum of three months' worth of ratings.

NTRA Financial Forecast

NTRA Earnings Forecast

Next quarter’s earnings estimate for NTRA is -$0.27 with a range of -$0.61 to $0.13. The previous quarter’s EPS was -$0.47. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.
Next quarter’s earnings estimate for NTRA is -$0.27 with a range of -$0.61 to $0.13. The previous quarter’s EPS was -$0.47. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Sales Forecast

Next quarter’s sales forecast for NTRA is $707.64M with a range of $676.93M to $720.00M. The previous quarter’s sales results were $752.75M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.
Next quarter’s sales forecast for NTRA is $707.64M with a range of $676.93M to $720.00M. The previous quarter’s sales results were $752.75M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Stock Forecast FAQ

What is NTRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Natera’s 12-month average price target is 400.08.
    What is NTRA’s upside potential, based on the analysts’ average price target?
    Natera has 18.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is NTRA a Buy, Sell or Hold?
          Natera has a consensus rating of Strong Buy which is based on 19 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Natera’s price target?
            The average price target for Natera is 400.08. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $480.00 ,the lowest forecast is $320.00. The average price target represents 18.82% Increase from the current price of $336.71.
              What do analysts say about Natera?
              Natera’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of NTRA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.